Market Overview:
The global clonidine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of hypertension, migraine, and glaucoma across the globe. Additionally, rising awareness about the benefits of clonidine therapy is also propelling the growth of this market. On the basis of type, circular patch segment is expected to account for a major share in terms of revenue in 2018 and is projected to maintain its dominance during forecast period as well. This can be attributed to their easy availability and low cost as compared with other patch types.
Product Definition:
Clonidine is a medication that is used to treat high blood pressure and other heart-related conditions. It can also be used to help with withdrawal symptoms from alcohol or other drugs.
Circular Patch:
Circular patch is a drug delivery device that uses the principle of osmosis to deliver drugs. It consists of an outer patch made up of semi-transparent plastic and an adhesive layer on the inside which holds the liquid medicine in place. The semi-transparent part allows passage of water but prevents absorption, therefore, no side effects are observed when used circularly for drug delivery.
Square Patch:
A square patch is a device that allows the measurement of plasma clonidine levels in patients. It is used to monitor the blood pressure drug Clonidine and other drugs that act as alpha-adrenergic receptor antagonist. The device works by allowing a small sample of patient's blood to be placed on an adhesive patch where it can then be analyzed for level of clonidine present using immunoassay techniques.
Application Insights:
The global clonidine market is segmented by application into high blood pressure, migraine, glaucoma, and others. In 2017, the high blood pressure application segment dominated the market with a share of over 60%. The growing prevalence of hypertension is one of the major factors driving this growth. According to a study published in NCBI in 2018, around 1 billion people have hypertension worldwide and it accounts for about 30% of all strokes.
Clonidine has been found to be effective in treating migraines as well as other pain disorders such as chronic neck pain and toothache. It also helps reduce sensitivity to light and sound which improves concentration during migraine attacks. This makes it an ideal drug for treating migraines while reducing anxiety caused by these attacks at the same time improving overall health outcomes over other drugs used for Migraine treatment such as sumatriptan or Imigran (sumatorelin).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool. The region is expected to maintain its dominance over the forecast period due to increasing awareness about chronic conditions and availability of advanced treatment options. In addition, rising preference for generic drugs is also expected to drive growth during this period.
Asia Pacific clonidine market is anticipated to grow at a lucrative rate during the forecast period owing to growing healthcare expenditure and prevalence of hypertension, glaucoma, and other ophthalmic disorders that are responsiveto drug therapy with lower doses of these medications than prescribed in North America or Europe.
The major companies operating in this industry are Takeda Pharmaceuticals U.S.A., Inc.; Dr Reddy's Laboratories; Mylan N.V.; Actavis LLC; Pfizer Inc.
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases: The global prevalence of hypertension was estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025. This will create a large pool of patients who will require treatment, including clonidine for control of blood pressure.
- Rising geriatric population: The number of people aged 60 years or older is expected to more than double from 841 million in 2015 to 2 billion by 2050, creating a large pool of patients with various age-related health conditions, including hypertension and other cardiovascular diseases that can be treated with clonidine.
- Growing awareness about the benefits of clonidine therapy: There is growing awareness among healthcare professionals and consumers about the benefits of clonidine therapy for the treatment of various conditions such as hypertension, ADHD, anxiety disorders, etc., which is likely to drive demand for this drug in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clonidine Market Research Report
By Type
Circular Patch, Square Patch, Others
By Application
High Blood Pressure, Migraine, Glaucoma, Others
By Companies
Physicians Total Care, Boehringer Ingelheim Promeco, Sanis Health, Pro Doc Limitee, Vintage Pharmaceuticals, Apotex, Mylan Pharmaceuticals, Corium International, Mayne Pharma, Advanz Pharma, Vintage Pharmaceuticals, Bioniche Pharma USA , Xanodyne Pharmaceuticals, Shionogi Pharma, Tris Pharma, Par Pharmaceutical, X Gen Pharmaceuticals, Teva Pharmaceutical Industries, PD-Rx Pharmaceuticals, Hikma Farmaceutica, Cadila Pharnmaceuticals, Alembic Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Clonidine Market Report Segments:
The global Clonidine market is segmented on the basis of:
Types
Circular Patch, Square Patch, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
High Blood Pressure, Migraine, Glaucoma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Physicians Total Care
- Boehringer Ingelheim Promeco
- Sanis Health
- Pro Doc Limitee
- Vintage Pharmaceuticals
- Apotex
- Mylan Pharmaceuticals
- Corium International
- Mayne Pharma
- Advanz Pharma
- Vintage Pharmaceuticals
- Bioniche Pharma USA
- Xanodyne Pharmaceuticals
- Shionogi Pharma
- Tris Pharma
- Par Pharmaceutical
- X Gen Pharmaceuticals
- Teva Pharmaceutical Industries
- PD-Rx Pharmaceuticals
- Hikma Farmaceutica
- Cadila Pharnmaceuticals
- Alembic Pharmaceuticals
Highlights of The Clonidine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Circular Patch
- Square Patch
- Others
- By Application:
- High Blood Pressure
- Migraine
- Glaucoma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clonidine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clonidine is a medication used to treat high blood pressure and other conditions. It works by decreasing the amount of blood that flows through your veins.
Some of the major companies in the clonidine market are Physicians Total Care, Boehringer Ingelheim Promeco, Sanis Health, Pro Doc Limitee, Vintage Pharmaceuticals, Apotex, Mylan Pharmaceuticals, Corium International, Mayne Pharma, Advanz Pharma, Vintage Pharmaceuticals, Bioniche Pharma USA , Xanodyne Pharmaceuticals, Shionogi Pharma, Tris Pharma, Par Pharmaceutical, X Gen Pharmaceuticals, Teva Pharmaceutical Industries, PD-Rx Pharmaceuticals, Hikma Farmaceutica, Cadila Pharnmaceuticals, Alembic Pharmaceuticals.
The clonidine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clonidine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clonidine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clonidine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clonidine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clonidine Market Size & Forecast, 2018-2028
4.5.1 Clonidine Market Size and Y-o-Y Growth
4.5.2 Clonidine Market Absolute $ Opportunity
Chapter 5 Global Clonidine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clonidine Market Size Forecast by Type
5.2.1 Circular Patch
5.2.2 Square Patch
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clonidine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clonidine Market Size Forecast by Applications
6.2.1 High Blood Pressure
6.2.2 Migraine
6.2.3 Glaucoma
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clonidine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clonidine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clonidine Analysis and Forecast
9.1 Introduction
9.2 North America Clonidine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clonidine Market Size Forecast by Type
9.6.1 Circular Patch
9.6.2 Square Patch
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clonidine Market Size Forecast by Applications
9.10.1 High Blood Pressure
9.10.2 Migraine
9.10.3 Glaucoma
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clonidine Analysis and Forecast
10.1 Introduction
10.2 Europe Clonidine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clonidine Market Size Forecast by Type
10.6.1 Circular Patch
10.6.2 Square Patch
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clonidine Market Size Forecast by Applications
10.10.1 High Blood Pressure
10.10.2 Migraine
10.10.3 Glaucoma
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clonidine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clonidine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clonidine Market Size Forecast by Type
11.6.1 Circular Patch
11.6.2 Square Patch
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clonidine Market Size Forecast by Applications
11.10.1 High Blood Pressure
11.10.2 Migraine
11.10.3 Glaucoma
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clonidine Analysis and Forecast
12.1 Introduction
12.2 Latin America Clonidine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clonidine Market Size Forecast by Type
12.6.1 Circular Patch
12.6.2 Square Patch
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clonidine Market Size Forecast by Applications
12.10.1 High Blood Pressure
12.10.2 Migraine
12.10.3 Glaucoma
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clonidine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clonidine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clonidine Market Size Forecast by Type
13.6.1 Circular Patch
13.6.2 Square Patch
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clonidine Market Size Forecast by Applications
13.10.1 High Blood Pressure
13.10.2 Migraine
13.10.3 Glaucoma
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clonidine Market: Competitive Dashboard
14.2 Global Clonidine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Physicians Total Care
14.3.2 Boehringer Ingelheim Promeco
14.3.3 Sanis Health
14.3.4 Pro Doc Limitee
14.3.5 Vintage Pharmaceuticals
14.3.6 Apotex
14.3.7 Mylan Pharmaceuticals
14.3.8 Corium International
14.3.9 Mayne Pharma
14.3.10 Advanz Pharma
14.3.11 Vintage Pharmaceuticals
14.3.12 Bioniche Pharma USA
14.3.13 Xanodyne Pharmaceuticals
14.3.14 Shionogi Pharma
14.3.15 Tris Pharma
14.3.16 Par Pharmaceutical
14.3.17 X Gen Pharmaceuticals
14.3.18 Teva Pharmaceutical Industries
14.3.19 PD-Rx Pharmaceuticals
14.3.20 Hikma Farmaceutica
14.3.21 Cadila Pharnmaceuticals
14.3.22 Alembic Pharmaceuticals
